ALLISON GUILLARD: Open Payments
NPI 1407385479 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 18 payments from 7 companies in 2025. Trend: 2023 $524 · 2024 $212 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 6 | $142 |
| ABBVIE INC. | 4 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $65 |
| Procept Biorobotics Corporation | 2 | $41 |
| UROGEN PHARMA, INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: AVEED, BOTOX, GEMTESA, AQUABEAM ROBOTIC SYSTEM, JELMYTO, Xtandi, PLUVICTO.
Industry payments across PA — which companies pay providers there.
